Salus reports lower H1 profit on higher revenue

Ljubljana, 12 August - Salus, the Ljubljana-based pharmaceutical wholesaler, generated EUR 247 million in sales revenue in the first half of the year, an increase of 14% on the same period a year ago. Net profit was down by 13% to EUR 6.4 million, which the company linked to a successfully settled lawsuit against a pharmacy in receivership.